Metropolis Healthcare Ltds credit rating was revised by CRISIL, with a long-term rating reaffirmed at CRISIL AA- and the outlook changed from Stable to Positive. The company reported a revenue increase to Rs. 1,208 crore for fiscal 2024, with a projected cash accrual of Rs. 240-260 crore annually.